Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Sherman

Showing results (41-50 of 211) with videos related to

Pageof 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Nucleoside analogues and mitochondrial toxicityRussell Fleischer, Debra Boxwell, Kenneth E Sherman
Hepatology (Baltimore, Md.)|September 5, 2015
Human immunodeficiency virus and liver disease: An updateKenneth E Sherman, Juergen Rockstroh, David Thomas
AIDS Reviews|March 2, 2013
The changing epidemiology of liver disease in HIV patientsVincent Soriano, Pablo Barreiro, Kenneth E Sherman
AIDS (London, England)|January 26, 2017
Hepatitis delta and HIV infectionVincent Soriano, Kenneth E Sherman, Pablo Barreiro
Virus Research|May 26, 2006
Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activationElizabeth A Mann, Sandra Stanford, Kenneth E Sherman
Hepatology (Baltimore, Md.)|August 2, 2013
Human immunodeficiency virus and liver disease forum 2012Kenneth E Sherman, David Thomas, Raymond T Chung
Journal of Hepatology|October 1, 2019
In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patientsJason T Blackard, Awewura Kwara, Kenneth E Sherman
Hepatology Communications|March 7, 2019
Human immunodeficiency virus and liver disease: A comprehensive updateKenneth E Sherman, Marion G Peters, David Thomas
Hepatology (Baltimore, Md.)|June 1, 2007
HIV and liver disease forum: conference proceedingsKenneth E Sherman, Marion Peters, Margaret James Koziel
Gastroenterology & Hepatology|March 21, 2017
Drug-Induced Liver Injury in HIV PatientsGuy W Neff, Dushyantha Jayaweera, Kenneth E Sherman
Pageof 22

Showing results (41-50 of 211) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Nucleoside analogues and mitochondrial toxicityRussell Fleischer, Debra Boxwell, Kenneth E Sherman
Hepatology (Baltimore, Md.)|September 5, 2015
Human immunodeficiency virus and liver disease: An updateKenneth E Sherman, Juergen Rockstroh, David Thomas
AIDS Reviews|March 2, 2013
The changing epidemiology of liver disease in HIV patientsVincent Soriano, Pablo Barreiro, Kenneth E Sherman
AIDS (London, England)|January 26, 2017
Hepatitis delta and HIV infectionVincent Soriano, Kenneth E Sherman, Pablo Barreiro
Virus Research|May 26, 2006
Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activationElizabeth A Mann, Sandra Stanford, Kenneth E Sherman
Hepatology (Baltimore, Md.)|August 2, 2013
Human immunodeficiency virus and liver disease forum 2012Kenneth E Sherman, David Thomas, Raymond T Chung
Journal of Hepatology|October 1, 2019
In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patientsJason T Blackard, Awewura Kwara, Kenneth E Sherman
Hepatology Communications|March 7, 2019
Human immunodeficiency virus and liver disease: A comprehensive updateKenneth E Sherman, Marion G Peters, David Thomas
Hepatology (Baltimore, Md.)|June 1, 2007
HIV and liver disease forum: conference proceedingsKenneth E Sherman, Marion Peters, Margaret James Koziel
Gastroenterology & Hepatology|March 21, 2017
Drug-Induced Liver Injury in HIV PatientsGuy W Neff, Dushyantha Jayaweera, Kenneth E Sherman
Pageof 22